IL6 and Parkinson disease: Results showed the release of peripheral LPS-infusion induced inflammatory cytokines IL-1β, IL-6, and TNF-α in the PD+LPS+L-dopa group (*p < 0.05, **p < 0.01 vs. PD+saline+L-dopa, Figure 3C).